Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, the Netherlands; Department of Cardiovascular Medicine, University Hospital Münster, Münster, Germany.
Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, the Netherlands; Department of Physiology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, the Netherlands.
JACC Cardiovasc Imaging. 2014 Jun;7(6):620-6. doi: 10.1016/j.jcmg.2014.01.017.
Intermittent dyssynchrony, induced by ventricular pacing, during early reperfusion reduces infarct size in pre-clinical studies. We evaluated cardioprotection by pacing post-conditioning (PPC) in ST-segment elevation myocardial infarction in a randomized, controlled, single-center, single-blinded, first-in-man study. Patients with first ST-segment elevation myocardial infarction received either PPC plus percutaneous coronary intervention (PCI) (n = 30) or PCI (n = 30). PPC consisted of 10 episodes of 30-s right ventricular pacing. Infarct size was measured as the area under the curve of creatine kinase (CK) (primary endpoint) and by contrast-enhanced cardiac magnetic resonance. The CK area under the curve was not significantly different between study groups. Adjusted contrast-enhanced cardiac magnetic resonance data showed ∼25% smaller infarct size in PPC + PCI than in PCI patients after 4 days (p = 0.01), 4 months (p = 0.02), and 1 year of PCI (p = 0.08). In PPC + PCI, (uncomplicated) ventricular fibrillation (n = 3) and paroxysmal atrial fibrillation (n = 4) were observed as opposed to 1 and 0 cases in PCI, respectively. We conclude PPC is feasible and may induce cardioprotection during PCI treatment of ST-segment elevation myocardial infarction, but technical improvements are needed to improve safety. (PROTECT: Pacing to Protect Heart for Damage From Blocked Heart Vessel and From Re-opening Blocked Vessel[s]; NCT00409604).
在临床前研究中,心室起搏引起的间歇性失同步在早期再灌注期间会减少梗死面积。我们在一项随机、对照、单中心、单盲、首次人体研究中评估了起搏后处理 (PPC) 在 ST 段抬高型心肌梗死中的心脏保护作用。首次发生 ST 段抬高型心肌梗死的患者接受 PPC 加经皮冠状动脉介入治疗 (PCI)(n = 30)或单独 PCI(n = 30)。PPC 由 10 个 30 秒的右心室起搏组成。梗死面积通过肌酸激酶 (CK) 的曲线下面积(主要终点)和对比增强心脏磁共振来测量。研究组之间 CK 曲线下面积无显著差异。调整后的对比增强心脏磁共振数据显示,在接受 PCI 治疗 4 天后(p = 0.01)、4 个月后(p = 0.02)和 1 年后,PPC + PCI 组的梗死面积比单独 PCI 组小约 25%(p = 0.08)。在 PPC + PCI 组中,观察到(无并发症的)心室颤动(n = 3)和阵发性心房颤动(n = 4),而在 PCI 组中分别为 1 例和 0 例。我们得出结论,PPC 是可行的,可能在 PCI 治疗 ST 段抬高型心肌梗死期间诱导心脏保护作用,但需要改进技术以提高安全性。(PROTECT:起搏以保护心脏免受阻塞的血管和再开放阻塞的血管的损伤;NCT00409604)。